We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance

Results: 1-10 of 663

Amendments to German Drug Advertising Act
  • Baker & McKenzie
  • Germany
  • March 26 2013

Amendments have been made to the German Drug Advertising Act (HeilmittelwerbegesetzHWG) (Act) by the so-called "Second Act Amending Drug Law and

International news: focus on compliance - winter 2014
  • McDermott Will & Emery
  • China, European Union, Germany, Global, USA
  • December 2 2014

As regulatory oversight of companiesfrom Sarbanes Oxley and the Dodd-Frank Act to the Foreign Corrupt Practices Act (FCPA) and the UK Bribery

German Federal Supreme Court on whether therapy-related instructions may contribute to patentability in case of a claim directed to a substance for use in therapeutic treatment (decisions of February 25, 2014 Cases X ZB 513 and X ZB 613 Collagenase
  • BARDEHLE PAGENBERG Partnerschaft mbB
  • Germany
  • July 14 2014

Therapy-related instructions ("therapiebezogene Anweisungen") may contribute to patentability if they objectively aim at allowing, enhancing

Bolar exemption - C-66113 - Astellas Pharma referral to the CJ
  • D Young & Co
  • European Union, Germany
  • April 7 2014

The Dusseldorf Court of Appeal has referred questions to the Court of Justice of the European Union (CJ) concerning the applicability of the

Germany - unhealthy showdown
  • Freshfields Bruckhaus Deringer LLP
  • Germany
  • July 5 2013

The German government has signalled its intention to fight corruption in the healthcare sector before its current term of office comes to an end

Germany seeks stricter nanomaterial reporting rules under REACH
  • Shook Hardy & Bacon LLP
  • European Union, Germany
  • May 10 2013

German safety regulators have apparently sought a major nanotechnologyrelated revision of the European Union's Registration, Evaluation

Europese Commissie keurt Duitse steun voor innovatieve medische diensten goed
  • CMS DeBacker
  • European Union, Germany
  • December 18 2013

Het platform zal toelaten om medische diensten te verlenen van op afstand wanneer het onmogelijk is voor de dokters en de patiënten om elkaar te

Generic drug and API producers deal with the Bolar exemption
  • McDermott Will & Emery
  • Germany
  • February 26 2014

To allow generic drug companies to enter the market as seamlessly as possible after expiration of patent rights, the Bolar exemption allows certain

Sidley Austin LLP global pricing newsletter - volume three 2014
  • Sidley Austin LLP
  • Brazil, Canada, China, European Union, France, Germany, India, United Kingdom, USA
  • April 15 2014

On October 21, 2013, Brazil’s National Agency of Supplemental Health enacted Normative Resolution 388, which mandated that all private healthcare

EU pricing & reimbursement
  • Hogan Lovells
  • Belgium, Czech Republic, France, Germany, Italy, Netherlands, Russia, Spain, United Kingdom
  • November 10 2014

This newsletter provides comprehensive overviews of the system of pricing and reimbursement of medicinal products and medical devices in EU Member